HCPCS Level II
J9071
Injection, cyclophosphamide (auromedics), 5 mg
Codes near J9071
These sit next to J9071 in the CMS Level II file. All J codes
- J9063Injection, mirvetuximab soravtansine-gynx, 1 mg
- J9064Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg
- J9065Injection, cladribine, per 1 mg
- J9066Injection, bendamustine hydrochloride (avyxa), 1 mg
- J9070Cyclophosphamide, 100 mg
- J9072Injection, cyclophosphamide (frindovyx), 5 mg
- J9073Injection, cyclophosphamide (dr. reddy's), 5 mg
- J9074Injection, cyclophosphamide (sandoz), 5 mg
- J9075Injection, cyclophosphamide, not otherwise specified, 5 mg
- J9076Injection, cyclophosphamide (baxter), 5 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 55150-0270-99 | Cyclophosphamide | Eugia US LLC | 100 |
| 55150-0271-99 | Cyclophosphamide | Eugia US LLC | 200 |
| 55150-0272-01 | Cyclophosphamide | Eugia US LLC | 400 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.